Daxiang
Daxiang Biotech is a leading provider of human-relevant tumor models based on organoid-on-a-chip technology. The company develops patient-derived tumor organoid chip systems that recapitulate key features of the tumor microenvironment for drug efficacy evaluation and translational oncology research. Its Oncochip platform supports applications including drug screening, mechanism-of-action studies, and precision oncology. With a portfolio of diverse tumor models and integrated microphysiological systems, Daxiang Biotech partners with global pharmaceutical companies and research institutions to improve the predictive power of preclinical studies, accelerate oncology drugs and drugs for other pathological diseases, and reduce reliance on animal models.
